phenformin has been researched along with Adenocarcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianchi, A; Caraci, F; Chiechio, S; Chisari, M; Frasca, G; Pinto, A; Salomone, S; Sortino, MA | 1 |
Linman, JW; Silverstein, MN | 1 |
Anisimov, VN; Dilman, VM | 1 |
3 other study(ies) available for phenformin and Adenocarcinoma
Article | Year |
---|---|
Effects of phenformin on the proliferation of human tumor cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Culture Media; Glucose; Humans; Hypoglycemic Agents; Male; Neuroblastoma; Oncogene Protein p21(ras); Phenformin; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles | 2003 |
The influence of combined glycolytic inhibitor, respiratory inhibitor, and protein antagonist on experimental tumor growth.
Topics: Adenocarcinoma; Animals; Fluorides; Injections, Intraperitoneal; Leukemia, Experimental; Leukemia, Lymphoid; Mammary Neoplasms, Experimental; Melphalan; Mice; Phenformin; Sarcoma 37 | 1967 |
Effect of treatment with phenformin, diphenylhydantoin or L-dopa on life span and tumour incidence in C3H/Sn mice.
Topics: Adenocarcinoma; Aging; Animals; Female; Leukemia, Experimental; Levodopa; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Phenformin; Phenytoin | 1980 |